Guanfacine Tablet, Extended Release
Product Images NDC 63629-8161

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Guanfacine (NDC 63629-8161). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Image 05)

A line graph showing plasma concentration of Guanfacine (mg/mL) over time (hours) comparing Guanfacine extended-release tablets 1 mg QD and Tenex 1 mg QD. The y-axis measures plasma concentration (0 to 4 mg/mL) and the x-axis measures time from 0 to 24 hours. Two lines represent concentration profiles of each formulation over time.*

FDA Label Image

Figure 2 (Image 06)

A forest plot chart depicting fold changes and 90% confidence intervals in pharmacokinetic parameters (Cmax, AUC) of guanfacine under the influence of various CYP3A4/5 inhibitors, inducers, and other drugs. The chart compares changes due to ketoconazole, fluconazole, rifampin, efavirenz, oral methylphenidate, and lisdexamfetamine dimesylate relative to a reference.*

FDA Label Image

Figure 3 (Image 07)

A pharmacokinetic chart showing fold change and 90% confidence intervals for Cmax and AUC of two interacting drugs, Oral Methylphenidate and Lisdexamfetamine Dimesylate. The horizontal axis represents change relative to reference, ranging from 0.0 to 2.0, with plotted points near 1.0 indicating minimal change.*

FDA Label Image

Label Image (Lbl636298161)

Label for Guanfacine ER 1 mg extended-release tablet by Bryant Ranch Prepack. The white round tablet is identified as RJ70. The label indicates storage at 20°-25°C (68°-77°F) and includes a caution to keep all drugs out of reach of children. The package contains 30 tablets and displays the NDC 63629-8161 and lot number 1523487.*

FDA Label Image

Spl Guanfacine Figure 4

A line chart depicting treatment failure percentage over time in days, comparing Placebo (solid line) and SPD503 (dashed line). The x-axis represents time to treatment failure in days, and the y-axis shows treatment failure percentage. The chart shows retreatment failure increasing for both groups over time, with Placebo failure rates consistently higher than SPD503.*

FDA Label Image

Structure (Structure)

Chemical structure of guanfacine hydrochloride, showing the chlorinated aromatic ring, amide, and guanidine functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.